We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Trial enrollment more than doubled among those aged 75 ...

Only about one in five people with cancer enroll in clinical trials, and the largest barrier to participation may be far ...

Patient centricity is too frequently used as a buzzword in a grand vision statement or keynote address — so often that it can lose its meaning. For me, it is more than that. It is a credo that guides ...

A pair of assessments conducted by the American Society of Hematology (ASH) have helped identify roadblocks to improving diversity in clinical trials and elucidated the strategies ASH members use to ...

Three clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated significant positive results from novel triplet therapies in the treatment of relapsed or ...

Director, Sickle Cell Disease and Iron Overload Program, Fred Hutch Assistant Professor, Division of Hematology and Oncology, University of Washington School of Medicine Personalized care is very ...

Daniel Ermann, MD joined the Division of Hematology/Hematologic Malignancies as an Associate Professor in 2023 after completing his Hematology/Oncology fellowship at the Huntsman Cancer Institute of ...

TUS Monotherapy and TUS+Venetoclax (VEN) Doublet Therapy Show Broad Clinical Activity and Strong Safety Data in relapsed or refractory (R/R) Acute Myeloid Leukemia (AML) and Differentiate TUS from ...

Immunai, an AI biotech company specializing in mapping the human immune system, has announced a strategic collaboration with ...

Welcome to the Regeneron conference call to discuss its Factor XI development program. My name is Shannon, and I will be your operator for today's call. [Operator Instructions] Please note that this ...

– QT-019B Phase 1 trials for refractory Systemic Lupus Erythematosus (rSLE), cleared by US FDA and China NMPA, to begin enrolling patients – – FDA has granted Fast Track Designation to QT-019B for the ...